doc. MUDr. Andrea Janíková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 3514, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 176
2022
-
Realita zapojení molekulárně biologických metod do diagnostiky a stratifikace lymfoproliferativních onemocnění.
Year: 2022, type: Conference abstract
2021
-
Home-Based Aerobic and Resistance Exercise Interventions in Cancer Patients and Survivors: A Systematic Review
Cancers, year: 2021, volume: 13, edition: 8, DOI
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract
-
LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
The journal of molecular diagnostics., year: 2021, volume: 23, edition: 8, DOI
-
LYNX (Lymphoid next-generation sequencing): NGS panel a bioinformatický nástroj pro integrativní analýzu prognostických a prediktivních markerů B-buněčných lymfoproliferací.
Year: 2021, type: Conference abstract
-
miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors.
Year: 2021, type: Conference abstract
-
miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors
Blood, year: 2021, volume: 137, edition: 18, DOI
-
Pohybová aktivita jako účinný prostředek nefarmakologické péče v onkologii
Year: 2021, edition: 1., elektronické vyd., number of pages: 108 s.
-
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Leukemia, year: 2021, volume: 35, edition: 5, DOI
2020
-
Analysis mutational landscape in systemic anaplastic large cell lymphoma identifies novel prognostic markers
Year: 2020, type: Conference abstract